BY9

12-beta-D-glucopyranosyl-12,13-dihydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione

Created:	2019-11-04
Last modified:	2020-11-25

Find Related PDB Entry
1 entries where BY9 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	57
Chiral Atom Count	5
Bond Count	63
Aromatic Bond Count	24

2D diagram of BY9

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	12-beta-D-glucopyranosyl-12,13-dihydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione
Synonyms	rebeccamycin analogue
Systematic Name (OpenEye OEToolkits)	n/a
Formula	C₂₆ H₂₁ N₃ O₇
Molecular Weight	487.461
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	c1c7c(ccc1)c3c(c5c(c2C(=O)NC(c23)=O)c4ccccc4n5C6OC(C(C(C6O)O)O)CO)n7
SMILES	CACTVS	3.385	OC[CH]1O[CH]([CH](O)[CH](O)[CH]1O)n2c3ccccc3c4c2c5[nH]c6ccccc6c5c7C(=O)NC(=O)c47
SMILES	OpenEye OEToolkits	2.0.7	c1ccc2c(c1)c3c4c(c5c6ccccc6n(c5c3[nH]2)C7C(C(C(C(O7)CO)O)O)O)C(=O)NC4=O
Canonical SMILES	CACTVS	3.385	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)n2c3ccccc3c4c2c5[nH]c6ccccc6c5c7C(=O)NC(=O)c47
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1ccc2c(c1)c3c4c(c5c6ccccc6n(c5c3[nH]2)[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C(=O)NC4=O
InChI	InChI	1.03	InChI=1S/C26H21N3O7/c30-9-14-21(31)22(32)23(33)26(36-14)29-13-8-4-2-6-11(13)16-18-17(24(34)28-25(18)35)15-10-5-1-3-7-12(10)27-19(15)20(16)29/h1-8,14,21-23,26-27,30-33H,9H2,(H,28,34,35)/t14-,21-,22+,23-,26-/m1/s1
InChIKey	InChI	1.03	FAKJOUAYZNXZGV-QCUUGYDUSA-N

Related Resource References

Resource Name	Reference
PubChem	465911
ChEMBL	CHEMBL3589062

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.